LIN28A and metabolic dysfunction-associated steatotic liver disease: Taken together, this data suggested that small molecule inhibition of Lin28 with for example C1632 has the potential to shift lipid homeostasis in liver towards a healthier state in a genetic mouse model of NAFLD.